Jane Street’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
Other funds holding MLTX
Jane Street's MLTX Position: Q3 2026 in Review
Jane Street reduced its MoonLake Immunotherapeutics (MLTX) stake by 34% in Q3 2026, selling an estimated $4.79M and leaving 559,973 shares worth $6.55M. The position accounts for ﹤0.01% of the portfolio, ranked #3341.
Jane Street first reported a position in MLTX in Q1 2022 and has held it in 14 quarters since. The position peaked at $22.2M in Q4 2025. 168 funds tracked by Wall St. Rank hold MLTX as of Q3 2026.
- Jane Street held 559,973 shares of MoonLake Immunotherapeutics worth $6.55M as of Q3 2026.
- Jane Street sold 293,413 MoonLake Immunotherapeutics shares in Q3 2026, an estimated $4.79M.
- MoonLake Immunotherapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #3341 holding.
- Jane Street first reported a position in MoonLake Immunotherapeutics in Q1 2022 and has held it in 14 quarters since.
- Jane Street's MoonLake Immunotherapeutics position peaked at $22.2M in Q4 2025.
- 168 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.